IL1B and Alzheimer disease: Thus, we evaluated the growth promoting activity of the prototypical cytokines involved in the acute (IL-1β, IL-6) and chronic (IFN-γ) phases of the disease on S. aureus strains isolated from AD patients with mild, moderate and severe forms of the disease, respectively.